REDS — Redsense Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK70.06m
- SEK55.36m
- SEK28.18m
Annual income statement for Redsense Medical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 14.4 | 9.36 | 14.3 | 25 | 28.2 |
| Cost of Revenue | |||||
| Gross Profit | 9.96 | 10.4 | 11.3 | 13.2 | 18.1 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 23.6 | 18 | 24.5 | 28 | 28 |
| Operating Profit | -9.15 | -8.67 | -10.2 | -3 | 0.21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9.03 | -7.97 | -8.76 | -4.51 | 0.342 |
| Net Income After Taxes | -9.03 | -7.97 | -8.76 | -4.51 | 0.342 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.03 | -7.97 | -8.76 | -4.51 | 0.342 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.03 | -7.97 | -8.76 | -4.51 | 0.342 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.57 | -0.804 | -0.624 | -0.467 | 0.021 |
| Dividends per Share |